Potentiator Of Cancer Immunity Containing Rankl Antagonist

Patent No. EP2692359 (titled "Potentiator Of Cancer Immunity Containing Rankl Antagonist") was filed by Oriental Yeast on Mar 28, 2012. The application was issued on Jun 7, 2017.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
DEHMEL & BETTENHAUSENMar 6, 2018RUCKERL

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2692359

ORIENTAL YEAST
Application Number
EP12765137A
Filing Date
Mar 28, 2012
Status
Revoked
Jan 18, 2023
Publication Date
Jun 7, 2017